The epidemiology of nonsteroidal anti-inflammatory drugs

被引:54
|
作者
Tenenbaum, J [1 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Dept Med, Baycrest Geriatr Ctr,Toronto Hosp, Toronto, ON M5G 1X5, Canada
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY | 1999年 / 13卷 / 02期
关键词
cyclo-oxygenase-2 specific inhibitors; gastrointestinal toxicity; misoprostol; nonsteroidal anti-inflammatory drugs; omeprazole;
D O I
10.1155/1999/361651
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonsteroidal anti-inflammatory drug (NSAID) use has increased dramatically in the past two decades. A large proportion of the elderly population (more than 65 years of age) holds a current or recent NSAID prescription, accounting for approximately 90% of all NSAID prescriptions. Despite studies that advise finding alternatives for NSAIDs for the management of osteoarthritis, physicians often prescribe NSAIDs first for such common musculoskeletal conditions. Despite being identified as risk factors for gastrointestinal complications, the simultaneous use of two NSAIDs and the coadministration of NSAIDs with corticosteroids and with coumadin continue to occur. The point prevalence of NSAID-induced ulcers is 10% to 30%, and 15% to 35% of all peptic ulcer complications are caused by NSAIDs. The increased risk of gastrointestinal complications when NSAIDs are used is 3% to 5%. This risk increases with other identified risk factors leg, older age, previous gastrointestinal history, comorbid diseases and poor health). Gastrointestinal causes of hospitalization leg, gastrointestinal hemorrhage and perforation) and death have increased in parallel to increased NSAID use. 'Antiulcer' agents are prescribed twice as often in NSAID users, and the economic impact leg, diagnostic tests and hospitalization) is that about one-third of the arthritis budget has been dedicated to deal with gastrointestinal side effects of NSAIDs. Misoprostol and omeprazole have been shown to be cytoprotective for the gastroduodenal mucosa when NSAIDs are used, and misoprostol has been shown to reduce the risk of gastroduodenal ulcer complications. Eco nomic evaluations have suggested that these agents are a cost effective means of dealing with such NSAID-associated problems. Although no NSAID is totally safe, a number of studies have demonstrated that NSAIDs may be ranked according to relative gastrointestinal toxicity. The role of Helicobacter pylori in NSAID associated problems remains uncertain.
引用
下载
收藏
页码:119 / 122
页数:4
相关论文
共 50 条
  • [21] PHOTOSENSITIVITY TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    FIGUEINEDO, A
    TEIXEIRA, E
    POIARESBAPTISTA, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (02) : 139 - 140
  • [22] Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
    Kim, Stephen J.
    Flach, Allan J.
    Jampol, Lee M.
    SURVEY OF OPHTHALMOLOGY, 2010, 55 (02) : 108 - 133
  • [23] Topical nonsteroidal anti-inflammatory drugs
    Bhat, Chirag
    Rosenberg, Hans
    James, Daniel
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (36) : E1231 - E1231
  • [25] Nonsteroidal anti-inflammatory drugs and the kidney
    Stürmer, T
    Elseviers, MM
    De Broe, ME
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 161 - 163
  • [26] Therapy with nonsteroidal, anti-inflammatory drugs
    Bauer, H
    Märker-Hermann, E
    ORTHOPADE, 2003, 32 (12): : 1088 - 1094
  • [27] Novel nonsteroidal anti-inflammatory drugs
    Boutsen, Y
    Esselinckx, W
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1999, 62 (04): : 421 - 424
  • [28] Nonsteroidal Anti-Inflammatory Drugs and the Kidney
    Hoerl, Walter H.
    PHARMACEUTICALS, 2010, 3 (07): : 2291 - 2321
  • [29] NONSTEROIDAL ANTI-INFLAMMATORY DRUGS - A REVIEW
    ZARRO, V
    AMERICAN FAMILY PHYSICIAN, 1984, 30 (05) : 243 - 246
  • [30] NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND HYPERTENSION
    KISCH, ES
    FISCHEL, B
    YARON, M
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (04) : 344 - 345